{"id":"NCT00719862","sponsor":"Meda Pharmaceuticals","briefTitle":"A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies","officialTitle":"Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-036 in Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-08","primaryCompletion":"2007-11","completion":"2007-11","firstPosted":"2008-07-22","resultsPosted":"2010-01-28","lastUpdate":"2010-02-02"},"enrollment":481,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Placebo nasal spray","otherNames":[]},{"type":"DRUG","name":"0.15% azelastine hydrochloride Nasal Spray","otherNames":["astepro 0.15%"]}],"arms":[{"label":"Placebo Nasal Spray","type":"PLACEBO_COMPARATOR"},{"label":"0.15% azelastine hydrochloride nasal spray","type":"ACTIVE_COMPARATOR"}],"summary":"The Purpose of this study is to determine if one allergy medication (0.15% azelastine hydrochloride) is more effective than Placebo alone","primaryOutcome":{"measure":"Change From Baseline in 12-hour Reflective Total Nasal Symptom Score (AM and PM Combined)at 14 Days","timeFrame":"baseline and 14 days","effectByArm":[{"arm":"Placebo","deltaMin":17.72,"sd":3.31},{"arm":"Astepro 0.15%","deltaMin":17.74,"sd":3.54}],"pValues":[{"comp":"OG000 vs OG001","p":"0.005"}]},"eligibility":{"minAge":"12 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":17},"locations":{"siteCount":34,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":242},"commonTop":["Dysgusia","Nasal Discomfort","Headache"]}}